Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-066582
Filing Date
2017-03-02
Accepted
2017-03-02 07:13:07
Documents
83
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d280476d10k.htm 10-K 1166515
2 EX-21.1 d280476dex211.htm EX-21.1 1739
3 EX-23.1 d280476dex231.htm EX-23.1 1611
4 EX-31.1 d280476dex311.htm EX-31.1 6686
5 EX-31.2 d280476dex312.htm EX-31.2 6673
6 EX-32.1 d280476dex321.htm EX-32.1 4070
7 EX-32.2 d280476dex322.htm EX-32.2 4057
14 GRAPHIC g280476g15s90.jpg GRAPHIC 64015
  Complete submission text file 0001193125-17-066582.txt   5597408

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srra-20161231.xml EX-101.INS 891662
9 XBRL TAXONOMY EXTENSION SCHEMA srra-20161231.xsd EX-101.SCH 61556
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20161231_cal.xml EX-101.CAL 78314
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20161231_def.xml EX-101.DEF 255063
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20161231_lab.xml EX-101.LAB 516033
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20161231_pre.xml EX-101.PRE 385753
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37490 | Film No.: 17656897
SIC: 2834 Pharmaceutical Preparations